On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Tumori Foundation

InstitutionResearch output, impact & collaborations

Tumori Foundation is a institution indexed in ScholarIQ from OpenAlex.

What is known about Tumori Foundation?

ScholarIQrecord summary

Tumori Foundation is a research organisation in San Francisco, US. OpenAlex records 2,579 works and 197,462 citations for it. 434 researchers list it as their most recent affiliation.

How many works does Tumori Foundation have?

ScholarIQindexed works

Tumori Foundation has 2,579 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Tumori Foundation have?

ScholarIQcitation count

Tumori Foundation has 197,462 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Tumori Foundation?

ScholarIQresearcher count

Tumori Foundation has 434 researchers in the ScholarIQ index.

What is the average h-index at Tumori Foundation?

ScholarIQavg h-index

Tumori Foundation has an average h-index of 87.3 in OpenAlex.

What is the ROR of Tumori Foundation?

ScholarIQror

The ROR for Tumori Foundation is on the source record.

What is the OpenAlex record for Tumori Foundation?

ScholarIQopenalex

The OpenAlex for Tumori Foundation is on the source record.

Who are the most-cited researchers behind Tumori Foundation?

ScholarIQtop researchers by citations
1
Vincenzo Mazzaferro · Hepatocellular Carcinoma Treatment and Prognosis
781 works89,764 citations
2
Ugo Pastorino · Lung Cancer Diagnosis and Treatment
718 works29,698 citations
3
Siranoush Manoukian · BRCA gene mutations in cancer
362 works26,876 citations

What are the most-cited papers on Tumori Foundation?

ScholarIQmost cited works
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro, Josep M. Llovet, Rosalba Miceli, Sherrie Bhoori, Marcello Schiavo, Luigi Mariani, Tiziana Camerini, Sasan Roayaie, Myron Schwartz, Gian Luca Grazi, René Adam, P. Neuhaus, Mauro Salizzoni, Jordi Bruix, Alejandro Forner, Luciano De Carlis, Umberto Cillo, Andrew K. Burroughs, Roberto Troisi, Massimo Rossi, Giorgio Enrico Gerunda, Jan Lerut, Jacques Belghiti, I. Boin, Jean Gugenheim, Fedja A. Rochling, Bart van Hoek, Pietro Majno
The Lancet Oncology. 20082,043 CitationsOPEN ACCESS
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Bruno Sangro, Josepmaria Argemi, Maxime Ronot, Valérie Paradis, Tim Meyer, Vincenzo Mazzaferro, Peter Jepsen, Rita Golfieri, Peter R. Galle, Laura A. Dawson, María Reig
Journal of Hepatology. 2024766 Citations
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
William D. Travis, Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf, Paul A. Bunn, Tina Cascone, Jamie E. Chaft, Gang Chen, Teh‐Ying Chou, Wendy A. Cooper, Jeremy J. Erasmus, Carlos Gil Ferreira, Jin-Mo Goo, John V. Heymach, Fred R. Hirsch, Hidehito Horinouchi, Keith M. Kerr, Mark G. Kris, Deepali Jain, Young Tae Kim, Fernando López‐Ríos, Shun Lü, Tetsuya Mitsudomi, André Moreira, Noriko Motoi, Andrew G. Nicholson, Ricardo Oliveira, Mauro Papotti, Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe
Journal of Thoracic Oncology. 2020464 CitationsOPEN ACCESS
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
Edward K. Geissler, Andreas A. Schnitzbauer, C. Zülke, P. Lamby, Andrea Proneth, Christophe Duvoux, Patrizia Burra, Karl‐Walter Jauch, Markus Rentsch, Tom M. Ganten, Jan Schmidt, Utz Settmacher, Michael Heise, G. Rossi, Umberto Cillo, Norman M. Kneteman, René Adam, Bart van Hoek, Philippe Bachellier, Philippe Wolf, Lionel Rostaing, Wolf O. Bechstein, Magnus Rizell, James J. Powell, Ernest Hidalgo, Jean Gugenheim, Heiner Wolters, Jens Brockmann, André Roy, Ingrid Mutzbauer, Angela Schlitt, Susanne Beckebaum, Christian Graeb, Silvio Nadalin, Umberto Valente, Víctor Sánchez Turrión, Neville V. Jamieson, Tim Scholz, M. Colledan, Fred Fändrich, Thomas Becker, Gunnar Söderdahl, Olivier Chazouillères, Heikki Mäkisalo, Georges‐Philippe Pageaux, Rudolf Steininger, Thomas Soliman, Koert P. de Jong, Jacques Pirenne, Raimund Margreiter, Johann Pratschke, Antonio D. Pinna, Johann Hauss, Stefan Schreiber, Simone I. Strasser, Jürgen Klempnauer, Roberto Troisi, Sherrie Bhoori, Jan Lerut, Itxarone Bilbao, Christian Klein, Alfred Königsrainer, Darius F. Mirza, Gerd Otto, Vincenzo Mazzaferro, P. Neuhaus, Hans J. Schlitt
Transplantation. 2015424 CitationsOPEN ACCESS
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
Julie George, Vonn Walter, Martin Peifer, Ludmil B. Alexandrov, Danila Seidel, Frauke Leenders, Lukas Maas, Christian Müller, Ilona Dahmen, Tiffany M. Delhomme, Maude Ardin, Noémie Leblay, Graham Byrnes, Ruping Sun, Aurélien de Reyniès, Anne McLeer‐Florin, Graziella Bosco, Florian Malchers, Roopika Menon, Janine Altmüller, Christian Becker, Peter Nürnberg, Viktor Achter, Ulrich Lang, Peter M. Schneider, Magdalena Bogus, Matthew G. Soloway, Matthew D. Wilkerson, Yupeng Cun, James McKay, Denis Moro‐Sibilot, Christian Brambilla, Sylvie Lantuéjoul, Nicolas Lemaître, Alex Soltermann, Walter Weder, Verena Tischler, Odd Terje Brustugun, Marius Lund‐Iversen, Åslaug Helland, Steinar Solberg, Sascha Ansén, Gavin Wright, Benjamin Solomon, Luca Roz, Ugo Pastorino, Iver Petersen, Joachim H. Clement, Jörg Sänger, Jürgen Wolf, Martin Vingron, Thomas Zander, Sven Perner, William D. Travis, Stefan A. Haas, Magali Olivier, Matthieu Foll, Reinhard Büttner, D. Neil Hayes, Élisabeth Brambilla, Lynnette Fernandez‐Cuesta, Roman K. Thomas
Nature Communications. 2018377 CitationsOPEN ACCESS

How much of the research on Tumori Foundation is open access?

ScholarIQopen access share
89%OPEN ACCESS
Gold
44%
Green
33%
Hybrid
11%
Bronze
0%
Closed
11%

Related on ScholarIQ

470M+ articles · 14-day free trial